UY37316A - SOLID PHARMACEUTICAL DISPERSION OF A BCL-2 INHIBITOR, PHARMACEUTICAL COMPOSITIONS OF THIS, AND USES FOR CANCER TREATMENT - Google Patents
SOLID PHARMACEUTICAL DISPERSION OF A BCL-2 INHIBITOR, PHARMACEUTICAL COMPOSITIONS OF THIS, AND USES FOR CANCER TREATMENTInfo
- Publication number
- UY37316A UY37316A UY0001037316A UY37316A UY37316A UY 37316 A UY37316 A UY 37316A UY 0001037316 A UY0001037316 A UY 0001037316A UY 37316 A UY37316 A UY 37316A UY 37316 A UY37316 A UY 37316A
- Authority
- UY
- Uruguay
- Prior art keywords
- bcl
- inhibitor
- cancer treatment
- dispersion
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención se refiere a formulaciones farmacéuticas en dispersión sólida de Compuesto A: y al uso de estas formulaciones para tratar cáncer.The invention relates to solid dispersion pharmaceutical formulations of Compound A: and the use of these formulations to treat cancer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662359366P | 2016-07-07 | 2016-07-07 | |
EP16182455 | 2016-08-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY37316A true UY37316A (en) | 2018-01-31 |
Family
ID=56681951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001037316A UY37316A (en) | 2016-07-07 | 2017-07-03 | SOLID PHARMACEUTICAL DISPERSION OF A BCL-2 INHIBITOR, PHARMACEUTICAL COMPOSITIONS OF THIS, AND USES FOR CANCER TREATMENT |
Country Status (3)
Country | Link |
---|---|
TW (1) | TW201805003A (en) |
UY (1) | UY37316A (en) |
WO (1) | WO2018007556A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3876911A4 (en) * | 2018-11-06 | 2022-06-22 | Beijing InnoCare Pharma Tech Co., Ltd. | Amorphous solid dispersion comprising 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2986002B1 (en) | 2012-01-24 | 2014-02-21 | Servier Lab | NOVEL INDOLIZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
FR3008979B1 (en) * | 2013-07-23 | 2015-07-24 | Servier Lab | NOVEL PHOSPHATE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
-
2017
- 2017-07-03 UY UY0001037316A patent/UY37316A/en unknown
- 2017-07-05 TW TW106122603A patent/TW201805003A/en unknown
- 2017-07-06 WO PCT/EP2017/067015 patent/WO2018007556A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2018007556A1 (en) | 2018-01-11 |
TW201805003A (en) | 2018-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP19003773A (en) | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | |
ECSP19052302A (en) | BENZOOXAZOLE DERIVATIVES AS IMMUNOMODULATORS | |
CL2018003135A1 (en) | Aromatic derivatives of sulfonamide. | |
CL2017002494A1 (en) | Indolamine-2, 3- dioxygenase inhibitors for cancer treatment | |
EA201990495A1 (en) | BIARY COMPOUNDS APPLICABLE AS IMMUNOMODULATORS | |
CL2016003422A1 (en) | Lysine specific demethylase-1 inhibitors | |
MY196909A (en) | Boronic acid derivatives and therapeutic uses thereof | |
GEP20217211B (en) | Substituted carbonucleoside derivatives useful as anticancer agents | |
CL2016002735A1 (en) | Imidazo [4,5-c] quinolin-2-one compounds and their use to treat cancer | |
DOP2015000274A (en) | CHEMICAL COMPOUNDS | |
CL2016003423A1 (en) | Lysine specific demethylase-1 inhibitors | |
CR20170384A (en) | DERIVATIVES OF USEFUL REPLACED NUCLEOSIDS AS ANTINEOPLASIC AGENTS | |
CL2016001231A1 (en) | Autotaxin Inhibitor Compounds | |
TW201613901A (en) | New compounds | |
CL2015002767A1 (en) | Therapeutic compounds and compositions | |
CL2014002873A1 (en) | Compounds derived from pyrimidin-amine or triazin-amine, adn-pk inhibitors; pharmaceutical composition; and its use for the treatment of cancer. | |
CL2016003074A1 (en) | Compounds derived from 2-oxy-2-phenyl-n-5-pyrrolidin-3-ylamino-1,3,4-thiadiazol-2-ylacetamide, pharmaceutical composition gls1 inhibitors and their use to treat cancer. | |
MX2019013808A (en) | Compounds for treatment of cancer. | |
PH12019502363A1 (en) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds | |
EA201790949A1 (en) | SUBSTITUTED 2,4-DIAMINOCHINOLINES AS NEW ANTI-CANCER FACILITIES | |
DOP2018000238A (en) | ZESTE HOMOLOGIST ENHANCER INHIBITORS 2 | |
DOP2016000297A (en) | PHARMACEUTICAL COMPOSITIONS USEFUL TO TREAT INFECTIOUS DISEASES | |
UY36758A (en) | INHIBITORS OF THE ZESTE 2 HOMOLOGIST POTENTIATOR | |
BR112017002852A2 (en) | azetidinyloxyphenylpyrrolidine compounds | |
CL2019001053A1 (en) | Pharmaceutical formulations and methods to prepare them. |